← All organizations

Biomedical Research Foundation

Academic/Hospital

Also known as: BIOMEDCL RES FDN

Highest phase reached

Phase 3

First clinical trial

Aug 1, 2012

First marketed drug

Jan 9, 2015

Last known activity

May 1, 2015

Timeline

2010s

  1. Jan 9, 2015

    sodium fluoride (18F)— Marketing Organization

Drugs by trial phase (1 distinct, 1 trials)

Phase 3 (1 own, 0 via acquisition)

Indications

Marketed drugs (3)

Recent trials (2)

  • NCT01726088Lead sponsorPhase 2/Phase 3Aug 1, 2012
  • NCT01726088Reponsible party - principal investigatorPhase 2/Phase 3Aug 1, 2012

Details

Last known activity
May 1, 2015